Noninvasive Optical Imaging of UV‐Induced Squamous Cell Carcinoma in Murine Skin: Studies of Early Tumor Development and Vitamin D Enhancement of Protoporphyrin IX Production

Better noninvasive techniques are needed to monitor protoporphyrin IX (PpIX) levels before and during photodynamic therapy (PDT) of squamous cell carcinoma (SCC) of the skin. Our aim was to evaluate (1) multispectral fluorescent imaging of ultraviolet light (UV)‐induced cancer and precancer in a mouse model of SCC and (2) multispectral imaging and probe‐based fluorescence detection as a tool to study vitamin D (VD) effects on aminolevulinic acid (ALA)‐induced PpIX synthesis. Dorsal skin of hairless mice was imaged weekly during a 24‐week UV carcinogenesis protocol. Hot spots of PpIX fluorescence were detectable by multispectral imaging beginning at 14 weeks of UV exposure. Many hot spots disappeared after cessation of UV at week 20, but others persisted or became visible after week 20, and corresponded to tumors that eventually became visible by eye. In SCC‐bearing mice pretreated with topical VD before ALA application, our optical techniques confirmed that VD preconditioning induces a tumor‐selective increase in PpIX levels. Fluorescence‐based optical imaging of PpIX is a promising tool for detecting early SCC lesions of the skin. Pretreatment with VD can increase the ability to detect early tumors, providing a potential new way to improve efficacy of ALA‐PDT.

[1]  Scott C Davis,et al.  Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy , 2013, Photonics & lasers in medicine.

[2]  Sanjay Anand,et al.  Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models , 2015, Photonics West - Biomedical Optics.

[3]  Edward V Maytin,et al.  Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate. , 2010, Journal of biomedical optics.

[4]  J Moan,et al.  Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues. , 1997, Cancer letters.

[5]  Ulas Sunar,et al.  Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging , 2013, Biomedical optics express.

[6]  V. Labhasetwar,et al.  Optical imaging to map blood-brain barrier leakage , 2013, Scientific Reports.

[7]  H Stepp,et al.  Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. , 1997, Journal of photochemistry and photobiology. B, Biology.

[8]  P Lehmann,et al.  Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of δ-aminolaevulinic acid , 1999, British Journal of Cancer.

[9]  S. Campbell,et al.  Effect of MAL-photodynamic therapy on hypertrophic scarring. , 2010, Photodiagnosis and photodynamic therapy.

[10]  Sanjay Anand,et al.  Combination of Oral Vitamin D3 with Photodynamic Therapy Enhances Tumor Cell Death in a Murine Model of Cutaneous Squamous Cell Carcinoma , 2014, Photochemistry and photobiology.

[11]  A. Curnow,et al.  Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells. , 2007, Photochemistry and photobiology.

[12]  M A Weinstock,et al.  Nonmelanoma skin cancer in the United States: incidence. , 1994, Journal of the American Academy of Dermatology.

[13]  Hamid Dehghani,et al.  Fluorescence tomography characterization for sub-surface imaging with protoporphyrin IX. , 2008, Optics express.

[14]  Ryan W. Hick,et al.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. , 2012, The Journal of clinical investigation.

[15]  Edward V. Maytin,et al.  Clinical studies of combined photodynamic therapy using 5-fluorouracil and methyl-aminolevulinate in patients at high risk for squamous cell carcinoma , 2013, Photonics West - Biomedical Optics.

[16]  Delwyn Dyall-Smith,et al.  Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology , 2006 .

[17]  J Moan,et al.  Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5‐aminolevulinic acid in mice bearing mammary carcinoma , 1992, International journal of cancer.

[18]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[19]  Arjen Amelink,et al.  Extraction of intrinsic fluorescence from single fiber fluorescence measurements on a turbid medium. , 2012, Optics letters.

[20]  S. Campbell,et al.  Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. , 2011, Photodiagnosis and photodynamic therapy.

[21]  R. M. Szeimiesa,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .

[22]  F. D. de Gruijl Photocarcinogenesis: UVA vs. UVB Radiation , 2002, Skin Pharmacology and Physiology.

[23]  Stefan Andersson-Engels,et al.  Photodynamic therapy of nonmelanoma skin malignancies with topical delta-amino levulinic acid: diagnostic measurements , 1994, Other Conferences.

[24]  Filippo Piffaretti,et al.  Correlation between Protoporphyrin IX Fluorescence Intensity, Photobleaching, Pain and Clinical Outcome of Actinic Keratosis Treated by Photodynamic Therapy , 2013, Dermatology.

[25]  Quantitative fluorescence spectroscopy in turbid media using fluorescence differential path length spectroscopy. , 2008, Journal of biomedical optics.

[26]  Sanjay Anand,et al.  Biomodulatory approaches to photodynamic therapy for solid tumors. , 2012, Cancer letters.

[27]  E. Jeffes,et al.  Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. , 2004, Archives of dermatology.

[28]  K. Svanberg,et al.  Laser‐induced fluorescence studies of normal and malignant tumour tissue of rat following intravenous injection of δ‐amino levulinic acid , 1997, Lasers in surgery and medicine.

[29]  S. Feldman,et al.  Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. , 2011, Cutis.

[30]  Wiley Interscience,et al.  Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy , 2008, Lasers in surgery and medicine.

[31]  K D Paulsen,et al.  A spectrally constrained dual-band normalization technique for protoporphyrin IX quantification in fluorescence-guided surgery. , 2012, Optics letters.

[32]  Sanjay Anand,et al.  Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer , 2015, Cancer medicine.

[33]  M. Ichihashi,et al.  Involvement of changes in stratum corneum keratin in wrinkle formation by chronic ultraviolet irradiation in hairless mice , 2003, Experimental dermatology.

[34]  T. Delaney,et al.  Photodynamic therapy of cancer. , 1988, Comprehensive therapy.

[35]  C. Elmets,et al.  PHOTODYNAMIC THERAPY OF CHEMICALLY‐ AND ULTRAVIOLET B RADIATION‐INDUCED MURINE SKIN PAPILLOMAS BY CHLOROALUMINUM PHTHALOCYANINE TETRASULFONATE , 1992, Photochemistry and photobiology.

[36]  J. Kennedy,et al.  The Monitoring of ALA-Induced Protoporphyrin IX Accumulation and Clearance in Patients with Skin Lesions by In Vivo Surface-Detected Fluorescence Spectroscopy , 1999, Lasers in Medical Science.

[37]  R. Anderson,et al.  Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. , 1997, The Journal of investigative dermatology.

[38]  R. Stern The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. , 2012, Journal of the American Academy of Dermatology.

[39]  A. Lucky,et al.  Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. , 2003, Journal of the American Academy of Dermatology.

[40]  D. Salomon,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002, Journal of the American Academy of Dermatology.

[41]  T. Hasan,et al.  Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. , 2011, Cancer research.

[42]  Anthony J. Durkin,et al.  Quantitative fluorescence imaging of protoporphyrin IX through determination of tissue optical properties in the spatial frequency domain. , 2011, Journal of biomedical optics.

[43]  P. V. D. van de Kerkhof,et al.  Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. , 2005, The Journal of investigative dermatology.

[44]  Tayyaba Hasan,et al.  Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosis , 2014, Journal of biomedical optics.

[45]  Barbara A Gilchrest,et al.  A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. , 2004, Archives of dermatology.

[46]  D Piao,et al.  Design of near-infrared imaging probe with the assistance of ultrasound localization. , 2001, Applied optics.

[47]  Ann-Marie Wennberg,et al.  Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. , 2007, Journal of the American Academy of Dermatology.

[48]  M. Landthaler,et al.  Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. , 2003, The Journal of investigative dermatology.

[49]  P. Bjerring,et al.  PpIX fluorescence combined with auto‐fluorescence is more accurate than PpIX fluorescence alone in fluorescence detection of non‐melanoma skin cancer: An intra‐patient direct comparison study , 2012, Lasers in surgery and medicine.

[50]  B. Pogue,et al.  Image-guided diffuse optical fluorescence tomography implemented with Laplacian-type regularization. , 2007, Optics express.

[51]  A. Khachemoune,et al.  Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends , 2015, International journal of dermatology.

[52]  T. Hasan,et al.  Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells , 2006, British Journal of Cancer.

[53]  H. Soyer,et al.  Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. , 1998, Archives of dermatology.

[54]  T. Hasan,et al.  Low-Dose Methotrexate Enhances Aminolevulinate-Based Photodynamic Therapy in Skin Carcinoma Cells In vitro and In vivo , 2009, Clinical Cancer Research.

[55]  Hamid Dehghani,et al.  Subsurface diffuse optical tomography can localize absorber and fluorescent objects but recovered image sensitivity is nonlinear with depth. , 2007, Applied optics.

[56]  A. Curnow,et al.  Direct Comparison of δ‐Aminolevulinic Acid and Methyl‐Aminolevulinate‐Derived Protoporphyrin IX Accumulations Potentiated by Desferrioxamine or the Novel Hydroxypyridinone Iron Chelator CP94 in Cultured Human Cells , 2007 .